← Open Payments lookup

WENDI SELLERS: Open Payments

NPI 1750654539 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$426 in 19 payments from 10 companies in 2025. Trend: 2023 $114 · 2024 $409 · 2025 $426

Food & beverage: $426
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$77
Vanda Pharmaceuticals Inc.2$66
E.R. Squibb & Sons, L.L.C.2$59
ABBVIE INC.3$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$51
Lundbeck LLC2$41
Neurocrine BioSciences, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$20
Alkermes, Inc.1$17
Teva Pharmaceuticals USA, Inc.1$16

Products named: REXULTI, FANAPT, COBENFY, VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, INGREZZA, TRINTELLIX.

Industry payments across CA — which companies pay providers there.